High Court Urged By Doctors To Uphold Myriad Gene Patents

Law360, New York (March 14, 2013, 3:56 PM EDT) -- A group of doctors told the U.S. Supreme Court on Thursday that Myriad Genetics Inc. should be allowed to patent breast cancer genes it isolated, saying such protection fosters innovation in the fields of medical and genetic research.

The Association of American Physicians and Surgeons filed an amicus brief addressing the dispute over whether Myriad can patent breast cancer genes it has isolated. The case, which is scheduled for argument April 15, is before the high court following an August Federal Circuit ruling that found Myriad's...
To view the full article, register now.